Literature DB >> 9502648

Restrictive cardiomyopathy, atrioventricular block and mild to subclinical myopathy in patients with desmin-immunoreactive material deposits.

E Arbustini1, P Morbini, M Grasso, R Fasani, L Verga, O Bellini, B Dal Bello, C Campana, G Piccolo, O Febo, C Opasich, A Gavazzi, V J Ferrans.   

Abstract

OBJECTIVES: We present clinical data and heart and skeletal muscle biopsy findings from a series of patients with ultrastructural accumulations of granulofilamentous material identified as desmin.
BACKGROUND: Desmin cardiomyopathy is a poorly understood disease characterized by abnormal desmin deposits in cardiac and skeletal muscle.
METHODS: Clinical evaluation, endomyocardial and skeletal muscle biopsy, light and electron microscopy and immunohistochemistry were used to establish the presence of desmin cardiomyopathy.
RESULTS: Six hundred thirty-one patients with primary cardiomyopathy underwent endomyocardial biopsy (EMB). Ultrastructural accumulations of granulofilamentous material were found in 5 of 12 biopsy samples from patients with idiopathic restrictive cardiomyopathy and demonstrated specific immunoreactivity with anti-desmin antibodies by immunoelectron microscopy. Immunohistochemical findings on light microscopy were nonspecific because of a diffuse intracellular distribution of desmin. All five patients had atrioventricular (AV) block and mild or subclinical myopathy. Granulofilamentous material was present in skeletal muscle biopsy samples in all five patients, and unlike the heart biopsy samples, light microscopic immunohistochemical analysis demonstrated characteristic subsarcolemmal desmin deposits. Two patients were first-degree relatives (mother and son); another son with first-degree AV block but without myopathy or cardiomyopathy demonstrated similar light and ultrastructural findings in skeletal muscle. Electrophoretic studies demonstrated two isoforms of desmin--one of normal and another of lower molecular weight--in cardiac and skeletal muscle of the familial cases.
CONCLUSIONS: Desmin cardiomyopathy must be considered in the differential diagnosis of restrictive cardiomyopathy, especially in patients with AV block and myopathy. Diagnosis depends on ultrastructural examination of EMB samples or light microscopic immunohistochemical studies of skeletal muscle biopsy samples. Familial desminopathy may manifest as subclinical disease and may be associated with abnormal isoforms of desmin.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9502648     DOI: 10.1016/s0735-1097(98)00026-6

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  19 in total

Review 1.  Extracardiac medical and neuromuscular implications in restrictive cardiomyopathy.

Authors:  Claudia Stöllberger; Josef Finsterer
Journal:  Clin Cardiol       Date:  2007-08       Impact factor: 2.882

2.  Pioglitazone-induced heart failure in a patient with restrictive cardiomyopathy and metabolic myopathy.

Authors:  Josef Finsterer; Claudia Stöllberger
Journal:  Clin Res Cardiol       Date:  2009-02-09       Impact factor: 5.460

3.  Genetic basis and molecular biology of cardiac arrhythmias in cardiomyopathies.

Authors:  Ali J Marian; Babken Asatryan; Xander H T Wehrens
Journal:  Cardiovasc Res       Date:  2020-07-15       Impact factor: 10.787

Review 4.  Clinical Application of Genetic Testing in Heart Failure.

Authors:  Ana Morales; Ray Hershberger
Journal:  Curr Heart Fail Rep       Date:  2017-12

Review 5.  Genetic evaluation of familial cardiomyopathy.

Authors:  Daniel P Judge; Nicole M Johnson
Journal:  J Cardiovasc Transl Res       Date:  2008-04-22       Impact factor: 4.132

6.  Desmin aggregate formation by R120G alphaB-crystallin is caused by altered filament interactions and is dependent upon network status in cells.

Authors:  Ming Der Perng; Shu Fang Wen; Paul van den IJssel; Alan R Prescott; Roy A Quinlan
Journal:  Mol Biol Cell       Date:  2004-03-05       Impact factor: 4.138

7.  Familial restrictive cardiomyopathy with atrioventricular block without skeletal myopathy.

Authors:  Gustavo Iglesias Cubero; Gary Lasa Larraya; J Rodríguez Reguero
Journal:  Exp Clin Cardiol       Date:  2007

8.  Mitochondrial DNA mutations and mitochondrial abnormalities in dilated cardiomyopathy.

Authors:  E Arbustini; M Diegoli; R Fasani; M Grasso; P Morbini; N Banchieri; O Bellini; B Dal Bello; A Pilotto; G Magrini; C Campana; P Fortina; A Gavazzi; J Narula; M Viganò
Journal:  Am J Pathol       Date:  1998-11       Impact factor: 4.307

Review 9.  Pediatric cardiomyopathies: causes, epidemiology, clinical course, preventive strategies and therapies.

Authors:  Steven E Lipshultz; Thomas R Cochran; David A Briston; Stefanie R Brown; Peter J Sambatakos; Tracie L Miller; Adriana A Carrillo; Liat Corcia; Janine E Sanchez; Melissa B Diamond; Michael Freundlich; Danielle Harake; Tamara Gayle; William G Harmon; Paolo G Rusconi; Satinder K Sandhu; James D Wilkinson
Journal:  Future Cardiol       Date:  2013-11

Review 10.  Desminopathies: pathology and mechanisms.

Authors:  Christoph S Clemen; Harald Herrmann; Sergei V Strelkov; Rolf Schröder
Journal:  Acta Neuropathol       Date:  2012-11-11       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.